What is the primary objective of RoHS?

The primary objective of RoHS is to restrict hazardous substances in electrical and electronic equipment (EEE) to protect human health and the environment during waste management and recycling. Directive 2011/65/EU (RoHS 2), amended by (EU) 2015/863, limits ten substances—lead (Pb), mercury (Hg), cadmium (Cd), hexavalent chromium (Cr(VI)), PBB, PBDE, DEHP, BBP, DBP, DIBP—at 0.1% (1000 ppm) by weight in homogeneous materials (except 0.01% (100 ppm) for Cd), improving recyclability alongside WEEE.

Who is legally or professionally required to comply with RoHS?

Manufacturers, importers, and distributors placing EEE on the EU market are legally required to comply with RoHS, unless explicitly excluded. Scope covers all EEE categories in Annex I (e.g., appliances, IT, lighting, medical devices) with electrical/electronic components; exclusions include large-scale fixed installations, military equipment (Article 2(4)). Responsibilities include ensuring homogeneous materials meet thresholds or exemptions.

Does RoHS require an external audit or third-party certification?

No, RoHS does not require external audits or third-party certification. Compliance relies on self-assessment via EU Declaration of Conformity (DoC) and technical documentation (per EN IEC 63000:2018), retained 10 years for market surveillance. Risk-based verification uses supplier declarations and IEC 62321 testing; CE marking applies where relevant.

How often should an assessment for RoHS be performed?

A RoHS assessment must be performed at product design, upon supply chain changes, and periodically for ongoing compliance. Initial evaluation at market placement; re-assess for supplier changes, exemption expiries (Annex III/IV, time-limited via delegated acts), or delegated directive updates (e.g., 2023 review). Risk-based: annual for high-risk materials, integrated into change control.

What are the consequences of non-compliance with RoHS?

Non-compliance with RoHS results in decentralized Member State enforcement, including product withdrawal, recalls, sales bans, and fines. Penalties vary by country (no unified EU schedule); may include administrative fines, customs seizures, criminal liability. Risks arise from market surveillance detecting exceedances in homogeneous materials or invalid exemptions.

An RoHS be mapped to other international frameworks?

Yes, RoHS substance lists and thresholds align partially with frameworks like China RoHS 2 (core six substances, broader EEE scope, mandatory marking/E-PUP). However, divergences exist (e.g., no EU-style exemptions in China; phthalates absent). Use as baseline for global compliance, layering jurisdiction-specific requirements (e.g., California SB50 for select substances).

What is the first step to begin implementing RoHS?

The first step to implement RoHS is to conduct product scoping against Annex I categories and Article 2(4) exclusions. Map BOMs to homogeneous materials, identify potential restricted substances/exemptions, and assemble initial supplier declarations for technical file per EN IEC 63000.

What is the primary objective of ISO 13485?

The primary objective of ISO 13485:2016 is to specify requirements for a quality management system (QMS) enabling organizations to consistently provide medical devices and related services that meet customer and applicable regulatory requirements. This standard, structured across Clauses 4–8, emphasizes documented processes, risk-based controls, validation, traceability, and post-market surveillance for device lifecycle stages including design, production, distribution, installation, servicing, and disposal. It ensures objective evidence of QMS effectiveness through records retained for at least the device lifetime or two years post-release.

Who is legally or professionally required to comply with ISO 13485?

ISO 13485 applies to organizations whose activities involve one or more stages of the medical device lifecycle, including manufacturers, contract manufacturers, suppliers, importers, distributors, and service providers. Target entities include those handling design, production, sterilization, calibration, distribution, installation, servicing, or post-market activities. Organizations must identify their regulatory roles (e.g., manufacturer under EU MDR) and incorporate applicable regulatory requirements into the QMS, with no specific employee or revenue thresholds but scope tailored via documented justifications for exclusions, primarily in Clause 7.

Does ISO 13485 require an external audit or third-party certification?

ISO 13485 does not mandate external audits or third-party certification, as it is a voluntary standard for demonstrating QMS conformity. However, certification by accredited bodies via Stage 1 (readiness) and Stage 2 (implementation) audits, followed by annual surveillance and triennial recertification, is common for market access, regulatory alignment (e.g., EU MDR notified bodies), and supplier qualification. Internal audits (Clause 8.2.4) are required to verify QMS effectiveness.

How often should an assessment for ISO 13485 be performed?

Internal audits for ISO 13485 must be performed at planned intervals to ensure QMS conformity and effectiveness, with frequency determined by risk, process performance, and regulatory changes. Management reviews (Clause 5.6) occur at planned intervals, incorporating audit results, complaints, CAPA status, and trends. Certification involves annual surveillance audits post-initial two-stage process, with full recertification every three years.

What are the consequences of non-compliance with ISO 13485?

Non-compliance with ISO 13485 risks regulatory enforcement, product holds, recalls, fines, market withdrawal, and loss of certification. Audits reveal gaps in documentation, validation, or CAPA, leading to major nonconformities, corrective actions, or certification denial. Operationally, it exposes patient safety risks, supply chain failures, and increased liability, with records demanding retention for device lifetime to support investigations.

An ISO 13485 be mapped to other international frameworks?

Yes, ISO 13485 can be mapped to frameworks like ISO 9001:2015 (via Annex B correspondence), though it excludes certain ISO 9001 elements for regulatory focus. It aligns with ISO 14971 (risk management), IEC 62366-1 (usability), and supports regulatory convergence such as EU MDR QMS expectations and FDA QMSR (effective February 2, 2026), enabling integrated compliance without claiming dual conformity.

What is the first step to begin implementing ISO 13485?

The first step to implement ISO 13485 is to define the QMS scope, including organizational roles, applicable regulatory requirements, processes, and justifications for any exclusions (Clause 4.1–4.2). Document this in the quality manual with process interactions, then conduct a gap analysis against Clauses 4–8 to prioritize remediation, ensuring documented procedures, medical device files, and risk-based controls.

Standards Comparison

RoHS vs ISO 13485

RoHS

Mandatory

2011

EU regulation restricting hazardous substances in EEE

ISO 13485

Mandatory

2016

International standard for medical device quality management systems

Quick Verdict

RoHS restricts hazardous substances in EEE for EU market access, while ISO 13485 mandates QMS rigor for medical devices globally. Companies adopt RoHS to avoid bans and fines; ISO 13485 for certification, regulatory alignment, and patient safety.

Hazardous Substances

RoHS

Directive 2011/65/EU on RoHS in EEE

Cost

€€€€

Complexity

High

Implementation Time

6-12 months

Key Features

Restricts 10 hazardous substances at homogeneous material level
Open scope applies to all EEE unless excluded
Requires technical file and EU Declaration of Conformity
Time-limited exemptions reviewed via delegated acts
Tiered verification using IEC 62321 testing methods

Quality Management

ISO 13485

ISO 13485:2016 Medical devices Quality management systems

Cost

€€€€

Complexity

High

Implementation Time

12-18 months

Key Features

Risk-based controls for device safety and compliance
Design and development validation requirements
Supplier evaluation and outsourcing controls
Post-market surveillance and complaint handling
Traceability and medical device file mandates

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

RoHS Details

What It Is

RoHS (Directive 2011/65/EU, recast as RoHS 2, amended by 2015/863) is an EU regulation restricting hazardous substances in electrical and electronic equipment (EEE) to protect health and environment during waste management. It uses an open-scope approach (all EEE unless excluded) with homogeneous material concentration limits.

Key Components

Restricts 10 substances (Pb, Cd, Hg, Cr(VI), PBB, PBDE, 4 phthalates) at 0.1% (1000 ppm) or 0.01% (100 ppm for Cd) per homogeneous material.
Annex III/IV exemptions: time-limited, application-specific allowances.
Compliance via technical documentation, EU Declaration of Conformity (DoC), and CE marking.
Built on IEC 63000 for documentation and IEC 62321 for testing.

Why Organizations Use It

Mandated for EU market access; reduces recycling risks, ensures level playing field. Mitigates fines, recalls; enhances sustainability, supply chain resilience, and ESG reporting.

Implementation Overview

Risk-based: scope analysis, BoM review, supplier declarations, tiered testing (XRF screening, ICP-MS/GC-MS confirmation), technical files (10-year retention). Applies to manufacturers/importers of EEE; no certification but audit-ready evidence required. Suits all sizes, complex for global supply chains.

ISO 13485 Details

What It Is

ISO 13485:2016 is the international standard titled Medical devices — Quality management systems — Requirements for regulatory purposes. It provides a certifiable framework for organizations in the medical device lifecycle, emphasizing risk-based controls to ensure devices meet customer and regulatory requirements from design to post-market surveillance.

Key Components

Organized into Clauses 4–8: QMS/documentation (4), management responsibility (5), resources (6), product realization (7), measurement/improvement (8).
Over 20 documented procedures required, built on process approach and ISO 9001 compatibility.
Core principles: traceability, validation, regulatory integration, and continual improvement via CAPA.
Third-party certification via accredited bodies with stage audits and surveillance.

Why Organizations Use It

Enables market access (EU MDR, FDA QMSR alignment effective 2026).
Mitigates risks like recalls through supplier controls and post-market feedback.
Builds stakeholder trust and competitive edge in supply chains.

Implementation Overview

Phased: gap analysis, documentation, training, validation, audits.
Suits all sizes in medical devices globally; 9–18 months typical.
Requires internal audits and management reviews for certification.

Key Differences

Aspect	RoHS	ISO 13485
Scope	Hazardous substances restriction in EEE materials	QMS for medical device lifecycle processes
Industry	Electrical/electronic equipment manufacturers globally	Medical device manufacturers and suppliers
Nature	Mandatory EU directive with exemptions	Voluntary QMS certification standard
Testing	XRF screening, IEC 62321 lab analysis	Process validation, internal audits, IQ/OQ/PQ
Penalties	Fines, recalls, market bans by Member States	Loss of certification, audit findings

Scope

RoHS

Hazardous substances restriction in EEE materials

ISO 13485

QMS for medical device lifecycle processes

Industry

RoHS

Electrical/electronic equipment manufacturers globally

ISO 13485

Medical device manufacturers and suppliers

Nature

RoHS

Mandatory EU directive with exemptions

ISO 13485

Voluntary QMS certification standard

Testing

RoHS

XRF screening, IEC 62321 lab analysis

ISO 13485

Process validation, internal audits, IQ/OQ/PQ

Penalties

RoHS

Fines, recalls, market bans by Member States

ISO 13485

Loss of certification, audit findings

Frequently Asked Questions

Common questions about RoHS and ISO 13485

RoHS FAQ

ISO 13485 FAQ

You Might also be Interested in These Articles...

Your Guide to Implementing PCI DSS in Your Organization

Step-by-step guide to implementing PCI DSS in your organization. Achieve compliance, protect cardholder data, and reduce risks. Start securing payments today!

Why the SEC Stepped In: The Investor-Driven Push for Cybersecurity Transparency

Discover why the SEC's 2023 cybersecurity rules treat cyber risks as material financial threats. Explore the 'stick and carrot' approach for standardized disclo

Decoding Tomorrow's Regulations: How Advanced Compliance Tools Predict and Prepare for Future Shifts

Advanced compliance tools use AI, analytics & real-time monitoring to predict regulatory shifts, cut non-compliance costs 3x, and ensure audit readiness. Stay p

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Explore More Comparisons

See how RoHS and ISO 13485 compare against other standards

Other RoHS Comparisons

Other ISO 13485 Comparisons

What It Is

Key Components

Restricts 10 substances (Pb, Cd, Hg, Cr(VI), PBB, PBDE, 4 phthalates) at 0.1% (1000 ppm) or 0.01% (100 ppm for Cd) per homogeneous material.

Annex III/IV exemptions: time-limited, application-specific allowances.

Compliance via technical documentation, EU Declaration of Conformity (DoC), and CE marking.

Built on IEC 63000 for documentation and IEC 62321 for testing.

Implementation Overview

What It Is

Key Components

Organized into Clauses 4–8: QMS/documentation (4), management responsibility (5), resources (6), product realization (7), measurement/improvement (8).

Over 20 documented procedures required, built on process approach and ISO 9001 compatibility.

Core principles: traceability, validation, regulatory integration, and continual improvement via CAPA.

Third-party certification via accredited bodies with stage audits and surveillance.

Aspect

RoHS

ISO 13485

Scope

Hazardous substances restriction in EEE materials

QMS for medical device lifecycle processes

Industry

Electrical/electronic equipment manufacturers globally

Medical device manufacturers and suppliers

Nature

Mandatory EU directive with exemptions

Voluntary QMS certification standard

Testing

XRF screening, IEC 62321 lab analysis

Process validation, internal audits, IQ/OQ/PQ

Penalties

Fines, recalls, market bans by Member States

Loss of certification, audit findings